In the first large U.S. study of its kind, researchers from UC San Francisco found that immunotherapy is a safe approach that may help to improve the body’s response to insulin.
U.S. Trial of Immunotherapy Deemed Safe for Type 1 Diabetes
Posted in Medical Research